Sodium oligo-mannurarate 900mg

DRUG2 trials

Sponsors

Shanghai Greenvalley Pharmaceutical Co., Ltd.

Conditions

Alzheimer DiseaseCognitive ImpairmentMild to Moderate Alzheimer Disease

Phase 2

Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease

CompletedNCT01453569

Shanghai Greenvalley Pharmaceutical Co., Ltd.Alzheimer Disease, Cognitive Impairment

Start: 2011-10-31End: 2013-08-31Updated: 2015-01-27

Phase 3

An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's Disease

CompletedNCT02293915

Shanghai Greenvalley Pharmaceutical Co., Ltd.Cognitive Impairment, Mild to Moderate Alzheimer Disease

Start: 2014-04-01End: 2018-09-28Updated: 2018-10-10

Related Papers

A phase II randomized trial of sodium oligomannate in Alzheimer's dementia.

2020-09-1457 citations